Definigen Competitors and Similar CompaniesClear all

Definigen's competitors and similar companies include Mirimus, Sana Biotechnology and Editas Medicine.
Definigen
Definigen
Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids.
Mirimus
Mirimus
Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.
Sana Biotechnology
Sana Biotechnology
Sana Biotechnology is a company specializing in cell and gene therapy.
Editas Medicine
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Founding Date
Founding Date
2012
Founding Date
2010
Founding Date
2018
Founding Date
2013
Type
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Babraham, GB HQ
Locations
Brooklyn, US HQ
Locations
Seattle, US HQ
Cambridge, US
South San Francisco, US
Locations
Cambridge, US HQ
Boulder, US
Cambridge, US
Employees
Employees
26
Employees
63
Employees
42110% increase
Employees
20816% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
840.9 m
Valuation ($)
256.5 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($266.8m) (FY, 2024)
Net income
($237.1m) (FY, 2024)

Funding

Latest funding round
Latest funding round
$ 886.8k (over 6 years ago)
Latest funding round
$ 2m (over 14 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 9.1m
Total funding raised
N/A
Total funding raised
$ 700m
Total funding raised
$ 210m
For sources of this data, please see the company profile

View Company Profiles

Mirimus
HQ
Brooklyn, US
Employees
63

Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.

View company
Sana Biotechnology
HQ
Seattle, US
Employees
421↑ 10% increase

Sana Biotechnology is a company specializing in cell and gene therapy.

View company
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

View company